The Multicenter Trial SAKK 37/95 of Cladribine, Cyclophosphamide and Prednisone in the Treatment of Chronic Lymphocytic Leukemias and Low-Grade Non-Hodgkin’s Lymphomas

Publisher： Karger

E-ISSN： 1421-9662|117|1|40-47

ISSN： 0001-5792

Source： Acta Haematologica, Vol.117, Iss.1, 2006-11, pp. : 40-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effective Treatment of Indolent Non-Hodgkin’s Lymphomas with Mitoxantrone, Chlorambucil and Prednisone

By  

Oncology Research and Treatment, Vol. 28, Iss. 2, 2005-01 ,pp. : 73-78

Karger

Access to resources Recommend Favorite

Antibody Therapy with Rituximab for Patients with Low-Grade Non-Hodgkin’s Lymphoma

By  

Oncology Research and Treatment, Vol. 22, Iss. 3, 1999-07 ,pp. : 184-190

Karger

Access to resources Recommend Favorite

Acute Toxicity of Mitoxantrone, Chlorambucil and Prednisolone (MCP) versus MCP plus Rituximab in Low-Grade Non-Hodgkin’s Lymphoma – Interim Results of a Phase III Trial

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 164-166

Karger

Access to resources Recommend Favorite

Biomarkers in childhood non-Hodgkin’s lymphomas

By Dokmanovic Lidija  

Biomarkers in Medicine, Vol. 7, Iss. 5, 2013-10 ,pp. : 791-801

Future Medicine

Access to resources Recommend Favorite

Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody

By  

Oncology Research and Treatment, Vol. 38, Iss. 4, 2015-03 ,pp. : 185-192

Karger

Access to resources Recommend Favorite